For research use only. Not for human consumption.
AOD-9604 (Advanced Obesity Drug-9604) is a synthetic modified C-terminal fragment of human Growth Hormone (hGH 177-191) with an added tyrosine residue at the N-terminus.
$70.00
AOD-9604 (Advanced Obesity Drug-9604) is a synthetic modified C-terminal fragment of human Growth Hormone (hGH 177-191) with an added tyrosine residue at the N-terminus. It was designed to isolate the lipolytic properties of full-length growth hormone without inducing IGF-1 elevation, hyperglycemia, or peripheral insulin resistance.
Lipolysis & Adipocyte Breakdown: Studied for its ability to stimulate $\beta_3$-adrenergic receptor pathways, accelerating the breakdown of stored triglycerides in white adipose tissue.
Inhibition of Lipogenesis: Evaluated for its capacity to suppress lipogenic pathways, preventing the formation and accumulation of new fat storage within adipocytes.
Cartilage & Joint Remodeling: Researched in musculoskeletal models for its synergistic potential in extracellular matrix repair, chondrocyte proliferation, and cartilage tissue preservation.
To provide a lipolytic hGH fragment analog for investigating targeted adipose tissue metabolism, non-glycemic growth hormone pathways, and chondrogenic tissue remodeling in laboratory research.
| Property | Details |
| Product Name | AOD-9604 |
| Product Category | Metabolic & Lipolytic Peptides |
| Compound Type | Synthetic Modified C-Terminal hGH Fragment (Tyr-hGH 177-191) |
| Primary Goal | Targeted lipolysis, lipogenesis inhibition, and cartilage repair research |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. Protect from direct light. |
| Intended Use | Laboratory Research Only |
| Dosage | 5MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.
